Nowadays, insulin continues to be an agent of ordinary and necessary use in the pharmacological treatment of diabetes, firstly in T1DM and in gestational diabetes, where insulin is the only pharmacological option and the only considerable replacement therapy. This evidence concerns the gene INS and gestational diabetes.